The Effectiveness of Nonsurgical Interventions for Weight Loss Maintenance in Adults: An Updated, GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Clinical Trials
- PMID: 39311875
- DOI: 10.1093/nutrit/nuae128
The Effectiveness of Nonsurgical Interventions for Weight Loss Maintenance in Adults: An Updated, GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Clinical Trials
Abstract
Context: Today, there are many discussions about the best way to maintain weight and prevent weight regain after a period of weight loss.
Objectives: The aim of this study was to summarize, based on data from randomized clinical trials (RCTs), the impact of nonsurgical interventions for adults' weight loss maintenance.
Data sources: The Medline (PubMed), Scopus, and Web of Science databases were reviewed during June 2023.
Data extraction: Meta-analyses assessing the impacts of nonsurgical interventions for weight loss maintenance were conducted. Effect sizes of nutritional interventions were recalculated by applying a random-effects model. The Grading of Recommendations, Assessment, Development, and Evaluation framework was implemented to determine evidence certainty.
Results: Meta-analysis of data from a total of 56 RCTs (n = 13 270 participants) represented a significant weight reduction after behavior and lifestyle interventions (mean difference [MD], -0.64 kg [95% CI, -1.18 to -0.09]; I2 = 89.5%; P < .001 for heterogeneity). Pharmacological interventions had also a significant effect on weight change during the weight maintenance phase (MD, -2.57 kg [95% CI, -3.12 to -2.02]; I2 = 91.6%; P < .001 for heterogeneity). The weight loss reduction from pharmacological interventions was greater with sibutramine (MD, -2.57; 95% CI: -3.12 to -2.02). Additionally, diet intervention and dietary and physical activity strategies were associated with a negligible trending decrease in weigh regain (respectively: MD, -0.91 kg [95% CI, -2.18 to 0.36], I2 = 55.7%, P = .016 for heterogeneity; and MD, -0.3 kg [95% CI, -4.13 to 3.52], I2 = 94.1%, P < .001).
Conclusion: The findings of this review indicate there is a favorable impact of behavior-based interventions and antiobesity medications on weight maintenance.
Systematic review registration: PROSPERO registration no CRD42023468056.
Keywords: activity; behavioral approach; exercise; obesity; overweight; physical; weight loss maintenance; weight management.
© The Author(s) 2024. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Similar articles
-
Body weight management in overweight and obese breast cancer survivors.Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD012110. doi: 10.1002/14651858.CD012110.pub2. Cochrane Database Syst Rev. 2020. PMID: 33305350 Free PMC article.
-
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812. JBI Database System Rev Implement Rep. 2015. PMID: 26447010
-
Interventions for weight loss in people with chronic kidney disease who are overweight or obese.Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013119. doi: 10.1002/14651858.CD013119.pub2. Cochrane Database Syst Rev. 2021. PMID: 33782940 Free PMC article.
-
Web-Based Digital Health Interventions for Weight Loss and Lifestyle Habit Changes in Overweight and Obese Adults: Systematic Review and Meta-Analysis.J Med Internet Res. 2019 Jan 8;21(1):e298. doi: 10.2196/jmir.9609. J Med Internet Res. 2019. PMID: 30622090 Free PMC article.
-
A systematic review and meta-analysis of weight loss in control group participants of lifestyle randomized trials.Sci Rep. 2022 Jul 18;12(1):12252. doi: 10.1038/s41598-022-15770-x. Sci Rep. 2022. PMID: 35851070 Free PMC article.
Cited by
-
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss.Biomolecules. 2025 Mar 13;15(3):408. doi: 10.3390/biom15030408. Biomolecules. 2025. PMID: 40149944 Free PMC article. Review.
-
The regulation on the use of supplements for weight control: Case studies from Australia, the United States of America, and the United Kingdom.Health Policy Open. 2025 Feb 16;8:100136. doi: 10.1016/j.hpopen.2025.100136. eCollection 2025 Jun. Health Policy Open. 2025. PMID: 40084066 Free PMC article. Review.